CADE clears Cristália’s acquisition of Takeda’s Jaguariúna plant
( July 3, 2026, 13:16 GMT | Official Statement) -- MLex Summary: Brazil’s competition authority has published the clearance of Cristália Produtos Químicos Farmacêuticos’ acquisition of Takeda Pharmaceuticals’ manufacturing plant in Jaguariúna after an in-depth merger review in the country's Official Journal. The transaction was initially submitted under the fast-track procedure but was later moved to a full-form investigation amid concerns that shifts in demand could affect the competitive assessment. In its review, the Superintendence concluded that the deal would not give rise to foreclosure concerns, finding no ability for the parties to restrict rivals’ access to the market. The deal was cleared unconditionally.See Official Journal publication below and report attached....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.